NLM logo
25 results
  1. ... the EURO-EWING-INTERGROUP-EE99 trial included vincristine, ifosfamide, doxorubicin, and etoposide (VIDE). This regimen is less dose intensive than the regimen employed ...
  2. ... or become refractory to conventional therapy, with a regimen including some combination of high-dose methotrexate, doxorubicin, cisplatin, ifosfamide, and etoposide. Two cohorts of patients are eligible ...
  3. ... vedotin in combination with the FRE-IGR-ALCL99 regimen of dexamethasone, cyclophosphamide, ifosfamide, etoposide, doxorubicin, IV methotrexate (3 g/m 2 arm), cytarabine, ...
  4. ... window Standard treatment Etoposide + cisplatin Etoposide + carboplatin Other regimens Cisplatin + irinotecan Ifosfamide + cisplatin + etoposide Cyclophosphamide + doxorubicin + etoposide Cyclophosphamide + doxorubicin + etoposide + vincristine Cyclophosphamide + etoposide + vincristine ...
  5. ... 18F-FDG PET response after three cycles of doxorubicin, vincristine, prednisone, and ... plus dexamethasone, etoposide, cisplatin, and cytarabine) for low- ...
  6. ... 2 ) + etoposide. Cytarabine (300 mg/m 2 ) + teniposide. Doxorubicin + ifosfamide. Doxorubicin + methotrexate (5 g/m 2 ). Etoposide + ifosfamide. References Dupuis LL, Milne-Wren C, Cassidy M, ...
  7. ... consisting of varying combinations of vincristine, cyclophosphamide, dactinomycin, doxorubicin, and ifosfamide. Disease evaluation, usually after four cycles of chemotherapy, ...
  8. ... 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide ...
  9. ... the kidney were treated with a new chemotherapeutic regimen combining vincristine, doxorubicin, cyclophosphamide, and etoposide in an attempt to further ...
  10. ... et al.: Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas. J Pediatr ...
previous · 1 · 2 · 3 · next